The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization 

Slides:



Advertisements
Similar presentations
The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization.
Advertisements

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,
Diabetes Management in Long-Term Care: An Exploratory Study of the Current Practices and Processes to Managing Frail Elderly Persons with Type 2 Diabetes.
Peter K. Smith, MD, Robert M. Califf, MD, Robert H
Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy  Jean-François Tanguay, MD, CSPQ, FRCPC, FACC,
The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment.
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice  Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure  Justin A. Ezekowitz, MBBCh, Eileen O'Meara,
The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment.
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.
The Demise of Morphine Oxygen Nitroglycerin Aspirin (MONA)
Management of Patients With Refractory Angina: Canadian Cardiovascular Society/Canadian Pain Society Joint Guidelines  Michael McGillion, RN, PhD, Heather.
Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation  Ratika Parkash, MD, MSc, François Philippon,
Transcatheter Aortic Valve Implantation: A Canadian Cardiovascular Society Position Statement  John Webb, MD, FRCPC, Josep Rodés-Cabau, MD, FRCPC, Stephen.
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization  Manesh R. Patel, MD, FACC, Steven.
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control 
Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016  Angela C. Webster, PhD, Evi V. Nagler, MD,
Guidelines for perioperative cardiac evaluation from the American College of Cardiology/American Heart Association task force are effective for stratifying.
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure  Justin A. Ezekowitz, MBBCh, Eileen O'Meara,
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice  Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,
The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure  Robert S. McKelvie, MD,
Sandra Lauck, RN, PhD, Dion Stub, MD, PhD, John Webb, MD 
Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M
The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy  John W.C.
Niv Ad, MD, Rakesh M. Suri, MD, DPhil, James S
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications 
The present day potential role of fractional flow reserve–guided coronary artery bypass graft surgery  Filip Casselman, MD, PhD, FETCS, Johan Van der.
Manesh R. Patel, MD, FACC, Gregory J
Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,
Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy  Jean-François Tanguay, MD, CSPQ, FRCPC, FACC,
Peter K. Smith, MD  The Journal of Thoracic and Cardiovascular Surgery 
Valve Replacement for Severe Aortic Stenosis With Low Transvalvular Gradient and Left Ventricular Ejection Fraction Exceeding 0.50  Giuseppe Tarantini,
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
Peter K. Smith, MD  The Annals of Thoracic Surgery 
Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery  Jeremy J. Pereira, MB, Krzysztof Balaban, MD,
Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical.
Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy  Eric J. Velazquez, MD,
Juan A. Crestanello, MD, Richard C. Daly, MD 
Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.
Why surgery won the SYNTAX trial and why it matters
New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery  Giovanni Filardo, PhD, MPH, Cody Hamilton,
Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS 
Michael E. Halkos, MD, MSc, Henry A
Systematizing Inpatient Referral to Cardiac Rehabilitation 2010: Canadian Association of Cardiac Rehabilitation and Canadian Cardiovascular Society Joint.
Spontaneous Coronary Artery Dissection and Fibromuscular Dysplasia
Donald S. Likosky, PhD, Stephen D. Surgenor, MD, Robert S
Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p
Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: When is preoperative coronary angiography necessary?  Nassir M.
Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD 
Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact  Jack V. Tu, MD, PhD, Anam M. Khan,
For everything there is a season
Peter K. Smith, MD, Robert M. Califf, MD, Robert H
Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality  Edward L. Hannan, PhD, Zaza Samadashvili,
To bypass or stent? The changing rules of an advancing game
The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment.
The Effect of Intravenous Vitamin C Infusion on Periprocedural Myocardial Injury for Patients Undergoing Elective Percutaneous Coronary Intervention 
Successful Use of Ranolazine in a Patient With Vasospastic Angina
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment.
Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.
CLINICAL OUTCOMES OF TREATMENT BY PERCUTANEOUS CORONARY INTERVENTION VERSUS CORONARY ARTERY BYPASS GRAFT SURGERY IN PATIENTS WITH CHRONIC KIDNEY DISEASE.
From Primary to Secondary Percutaneous Coronary Intervention: The Emerging Concept of Early Mechanical Reperfusion With Delayed Facilitated Stenting—When.
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management  Anne M. Gillis, MD, FRCPC, Atul Verma, MD, FRCPC, Mario.
The 2013 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment.
Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma.
Transatlantic editorial: A comparison between European and North American guidelines on myocardial revascularization  Philippe Kolh, MD, PhD, Paul Kurlansky,
The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization  Lorenzo Azzalini,
Mobile Medicine: Digital Dynamo or Virtual Vaporware
Revascularization in severe ventricular dysfunction (15% ≤ LVEF ≤ 30%): a comparison of bypass grafting and percutaneous intervention  Koichi Toda, MD,
Presentation transcript:

The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization  Gordon W. Moe, MD, MSc, FRCPC, Justin A. Ezekowitz, MB, BCh, MSc, FRCPC, Eileen O'Meara, MD, FRCPC, Jonathan G. Howlett, MD, FRCPC, Steve E. Fremes, MD, FRCPC, Abdul Al-Hesayen, MD, FRCPC, George A. Heckman, MD, MSc, FRCPC, Anique Ducharme, MD, FRCPC, Estrellita Estrella-Holder, RN, BN, MScA, CCN(C), Adam Grzeslo, MD, CCFP, FCFP, Karen Harkness, RN, BScN, CCNC, PhD, Serge Lepage, MD, FRCPC, Michael McDonald, MD, FRCPC, Robert S. McKelvie, MD, FRCPC, Anil Nigam, MD, MSc, FRCPC, Miroslaw Rajda, MD, FRCPC, Vivek Rao, MD, PhD, FRCPS, Elizabeth Swiggum, MD, FRCPC, Sean Virani, MD, FRCPC, Vy Van Le, MD, FRCPC, Shelley Zieroth, MD, FRCPC, J. Malcolm O. Arnold, MD, FRCPC, Tom Ashton, MD, FRCPC, Michel D'Astous, MD, FRCPC, Paul Dorian, MD, FRCPC, Nadia Giannetti, MD, FRCPC, Haissam Haddad, MD, FRCPC, Debra L. Isaac, MD, FRCPC, Simon Kouz, MD, FRCPC, FACC, Marie-Hélène Leblanc, MD, FRCPC, Peter Liu, MD, FRCPC, Heather J. Ross, MD, FRCPC, Bruce Sussex, MD, FRCPC, Michel White, MD, FRCPC  Canadian Journal of Cardiology  Volume 30, Issue 3, Pages 249-263 (March 2014) DOI: 10.1016/j.cjca.2013.10.010 Copyright © 2014 Canadian Cardiovascular Society Terms and Conditions

Figure 1 Approach to assessment for coronary artery disease in patients with heart failure. All patients with heart failure are expected to undergo noninvasive measurement of systolic function (not included in this algorithm). *Some centres might additionally perform noninvasive imaging, especially when coronary anatomy is not optimal. †If imaging indicates features of high risk, progression to coronary angiography is expected. ‡Noninvasive imaging might be performed in certain centres for risk stratification or diagnosis. PCI, percutaneous coronary intervention. Canadian Journal of Cardiology 2014 30, 249-263DOI: (10.1016/j.cjca.2013.10.010) Copyright © 2014 Canadian Cardiovascular Society Terms and Conditions

Figure 2 Decision regarding coronary revascularization in heart failure. It is recommended that surgical consultation be performed very early in this process. *Coronary anatomy suitable for CABG includes multivessel disease > 70% stenosis, left main stem stenosis > 50%, or diabetes with left anterior descending artery stenosis > 70%. †In selected cases in which there is noninvasive imaging evidence of extensive cardiac ischemia, PCI might be considered. AVR, aortic valve replacement; CABG, coronary artery bypass grafting; IC, intracoronary; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention. Canadian Journal of Cardiology 2014 30, 249-263DOI: (10.1016/j.cjca.2013.10.010) Copyright © 2014 Canadian Cardiovascular Society Terms and Conditions